These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23229693)

  • 1. A randomized trial comparing the cost-effectiveness of 2 approaches for treating unilateral nasolacrimal duct obstruction.
    Pediatric Eye Disease Investigator Group
    Arch Ophthalmol; 2012 Dec; 130(12):1525-33. PubMed ID: 23229693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing for congenital nasolacrimal duct obstruction.
    Petris C; Liu D
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011109. PubMed ID: 28700811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of treatment approaches for bilateral congenital nasolacrimal duct obstruction.
    Lee KA; Chandler DL; Repka MX; Melia M; Beck RW; Summers CG; Frick KD; Foster NC; Kraker RT; Atkinson S;
    Am J Ophthalmol; 2013 Nov; 156(5):1045-50. PubMed ID: 23954210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Office probing for treatment of nasolacrimal duct obstruction in infants.
    Miller AM; Chandler DL; Repka MX; Hoover DL; Lee KA; Melia M; Rychwalski PJ; Silbert DI; ; Beck RW; Crouch ER; Donahue S; Holmes JM; Quinn GE; Sala NA; Schloff S; Wallace DK; Foster NC; Frick KD; Golden RP; Lambert SR; Tien DR; Weakley DR
    J AAPOS; 2014 Feb; 18(1):26-30. PubMed ID: 24568978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Office- or Facility-Based Probing for Congenital Nasolacrimal Duct Obstruction: A Report by the American Academy of Ophthalmology.
    Morrison DG; Binenbaum G; Chang MY; Heidary G; Trivedi RH; Galvin JA; Pineles SL
    Ophthalmology; 2021 Jun; 128(6):920-927. PubMed ID: 33358412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasolacrimal Duct Probing under Topical Anesthesia for Congenital Nasolacrimal Duct Obstruction in Taiwan.
    Hung CH; Chen YC; Lin SL; Chen WL
    Pediatr Neonatol; 2015 Dec; 56(6):402-7. PubMed ID: 26026949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution of congenital nasolacrimal duct obstruction with nonsurgical management.
    Pediatric Eye Disease Investigator Group
    Arch Ophthalmol; 2012 Jun; 130(6):730-4. PubMed ID: 22801833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of 2 approaches to managing nasolacrimal duct obstruction in infants: the importance of the spontaneous resolution rate.
    Frick KD; Hariharan L; Repka MX; Chandler D; Melia BM; Beck RW;
    Arch Ophthalmol; 2011 May; 129(5):603-9. PubMed ID: 21555614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasolacrimal duct office probing in children under the age of 12 months: Cure rate and cost evaluation.
    Le Garrec J; Abadie-Koebele C; Parienti JJ; Molgat Y; Degoumois A; Mouriaux F
    J Fr Ophtalmol; 2016 Feb; 39(2):171-7. PubMed ID: 26826746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years.
    ; Repka MX; Chandler DL; Beck RW; Crouch ER; Donahue S; Holmes JM; Lee K; Melia M; Quinn GE; Sala NA; Schloff S; Silbert DI; Wallace DK
    Ophthalmology; 2008 Mar; 115(3):577-584.e3. PubMed ID: 17996306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat probing for treatment of persistent nasolacrimal duct obstruction.
    ; Repka MX; Chandler DL; Bremer DL; Collins ML; Lee DH
    J AAPOS; 2009 Jun; 13(3):306-7. PubMed ID: 19541274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early office-based vs late hospital-based nasolacrimal duct probing. A clinical decision analysis.
    Kassoff J; Meyer DR
    Arch Ophthalmol; 1995 Sep; 113(9):1168-71. PubMed ID: 7661751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of initial and repeated nasolacrimal duct office-based probing for congenital nasolacrimal duct obstruction.
    Cha DS; Lee H; Park MS; Lee JM; Baek SH
    Korean J Ophthalmol; 2010 Oct; 24(5):261-6. PubMed ID: 21052504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting the success of nasolacrimal duct probing for congenital nasolacrimal duct obstruction.
    Mannor GE; Rose GE; Frimpong-Ansah K; Ezra E
    Am J Ophthalmol; 1999 May; 127(5):616-7. PubMed ID: 10334364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital nasolacrimal duct obstruction: natural history and the timing of optimal intervention.
    Paul TO; Shepherd R
    J Pediatr Ophthalmol Strabismus; 1994; 31(6):362-7. PubMed ID: 7714699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Success rates of probing for congenital nasolacrimal duct obstruction at various ages.
    Świerczyńska M; Tobiczyk E; Rodak P; Barchanowska D; Filipek E
    BMC Ophthalmol; 2020 Oct; 20(1):403. PubMed ID: 33032542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Office probing of congenital nasolacrimal duct obstruction.
    Stager D; Baker JD; Frey T; Weakley DR; Birch EE
    Ophthalmic Surg; 1992 Jul; 23(7):482-4. PubMed ID: 1407947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-based comparison of successful probing in Nepalese children with nasolacrimal duct obstruction.
    Limbu B; Akin M; Saiju R
    Orbit; 2010 Feb; 29(1):16-20. PubMed ID: 20302404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimetabolites as an adjunct to dacryocystorhinostomy for nasolacrimal duct obstruction.
    Phelps PO; Abariga SA; Cowling BJ; Selva D; Marcet MM
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012309. PubMed ID: 32259290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing for congenital nasolacrimal duct obstruction in older children.
    Eshragi B; Fard MA; Masomian B; Akbari M
    Middle East Afr J Ophthalmol; 2013; 20(4):349-52. PubMed ID: 24339688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.